Purine derivatives as adenosine A1 receptor agonists and methods of use thereof
US8183224B2 · kind B2 · utility
5Cited by
33References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 4, 2008 |
| Grant date | May 22, 2012 |
| Priority date | — |
| Expiry date | Apr 28, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to Purine Derivatives; compositions comprising an effective amount of a Purine Derivative; and methods for reducing an animal's rate of metabolism, protecting an animal's heart against myocardial damage during cardioplegia; or for treating or preventing a cardiovascular disease, a neurological disorder, an ischemic condition, a reperfusion injury, obesity, a wasting disease, or diabetes, comprising administering an effective amount of a Purine Derivative to an animal in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.